Andy Jassi, Chief Executive Officer of Amazon.Com Inc., during the GeekWire Summit in Seattle, Washington, USA on Tuesday, October 10th. 5, 2021.
David Ryder | Bloomberg | Getty Images
Amazon is developing cancer vaccines in collaboration with the Fred Hutchinson Cancer Research Center and has recently entered clinical trials approved by the Food and Drug Administration.
Amazon and Fred Hutchinson plan to recruit 20 participants over the age of 18 for the early stage or phase 1 trial. application at ClinicalTrials.gov, a database of clinical trials maintained by the National Library of Medicine. The goal is to develop “personalized vaccines” that can treat breast cancer and melanoma, a form of skin cancer, the statement said.
According to the application, Fred Hutchinson is listed as a sponsor of the study and Amazon is listed as a co-author. The news of the partnership was first reported business insider. The study was first published last October and began on June 9th. It is expected to be completed by November. 1 from 2023.
An Amazon spokesperson confirmed the partnership and said it was led by Fred Hutch.
“Amazon is bringing scientific input and machine learning expertise in partnership with Fred Hatch to explore the development of personalized treatments for certain forms of cancer,” a CNBC spokesperson said. “It’s very early, but Fred Hutch recently got approval from the US Food and Drug Administration to start a phase I clinical trial and it’s not clear if it will be successful. It will be a long, multi-year process – if it develops. , we will be open to collaborating with other health and life sciences organizations that may also be interested in similar efforts.”
Representatives for Fred Hutch did not immediately respond to a request for comment.
In recent years, Amazon has expanded its presence in the healthcare industry. Company launched in 2020 online pharmacyit expanded its telemedicine service called Amazon careand it aspired develop home medical diagnostics.
A secret research and development group inside Amazon, known as the Grand Challenge, originally oversaw the cancer vaccine effort, according to Business Insider, citing people familiar with the matter. It’s now under the purview of a cancer research team reporting to Amazon VP of Devices Robert Williams, Business Insider reports.